News – AU – Three days to go to Cactus, Inc To buy (NYSE: WHD) before ex-dividend day

0
1

Readers using Cactus, Inc Wanting to buy (NYSE: WHD) for its dividend will have to make their move shortly as the stock is about to trade ex-dividend, meaning that investors who buy on or after March 26 Buy February stocks, don’t receive dividends March will be paid

Cactus’ next dividend payment is $ 0.9 per share, a year ago when the company paid a total of $ 036 to shareholders Calculating last year’s payment value shows Cactus has a trailing yield of 1.2% At the current share price of $ 2985, dividends add significantly to long-term owners’ return on investment, but only if the dividend continues to be paid, so readers should always check to see if Cactus has been able to increase its dividends or if the dividend may be reduced

When a company pays more dividends than it earns, the dividend can no longer be sustainable – hardly an ideal situation. Fortunately, Cactus’ payout ratio is modest at only 35% of earnings.A useful secondary test can be to assess whether Cactus Generated Enough Free Cash Flow To Afford Its Dividend It paid 12% of its free cash flow as dividends last year, which is conservatively low

It is gratifying to see that the dividend is covered by both earnings and cash flow, which generally suggests that the dividend is sustainable as long as earnings do not fall steeply

Companies with declining earnings are riskier for dividend shareholders If earnings plummet enough, the company could be forced to cut its dividend Cactus’ earnings have collapsed faster than Wile E Coyote’s to catch the Road Runner down by a massive 68% per year over the past five years

Unfortunately, Cactus has only been paying dividends for about a year, so there isn’t much history to glean from

Is it worth buying Cactus for its dividend? Cactus has comfortably low cash and payout ratios, which can mean the dividend is sustainable despite a sharp drop in earnings per share.Nevertheless, we view declining earnings as a warning sign that it might be worth investigating whether the company is reinvesting in growth projects that are in Future could lead to earnings and dividends, but at the moment we are not overly optimistic about the dividend outlook

Given that, while Cactus has an attractive dividend, it is worth knowing the risks associated with this stock. When it comes to investment risks, we’ve identified a warning sign with Cactus and understanding should be part of your investment process

A common investment mistake is buying the first interesting stock you see. Here’s a list of promising dividend stocks with a yield greater than 2% and an upcoming dividend

This article by Simply Wall St is of a general nature.It is not a recommendation to buy or sell stocks and does not take into account your goals or your financial situation.We aim to provide you with a long-term, focused analysis based on fundamental data. that our analysis may not reflect the latest price sensitive company announcements or quality materials Simply Wall St does not have a position in the stocks mentioned Do you have any feedback on this article? Concerned about the content? Contact us directly. Alternatively, you can also send an e-mail to the editorial team (at) simplywallstcom

Inflation expectations have risen sharply in recent months With rising inflation expectations, the yield on 10-year government bonds has risen to 1,37% from 067% since Sept. 23, the start of a rally in riskier assets benefiting from a firming economy However, the higher inflation forecast is causing some concern for equity investors

If billionaire Ray Dalio takes a step, Wall Street looks out for it Dalio, who began trading on the floor of the New York Stock Exchange, founded the world’s largest hedge fund, Bridgewater Associates, in 1975 with the company, which has global investments of around 140 Billions of dollars under management, and Dalio’s $ 17 billion in fortune earned him legendary status on Wall Street. Dalio sums up his success and offers three pieces of advice for investors to diversify. First, the surest way to invest well is by To hold a wide range of stocks from different sectors in your portfolio Second, don’t think that rising markets will rise forever. This is Dalio’s take on an old saw where past performance is no guarantee of future returns on Dalio’s Telling you that any strong past returns really guarantee it will turn out to be worth it m current high prices. Finally, Dalio says to investors, “Do the opposite of your instincts” In other words, do not follow the herd as such thinking often leads to suboptimal results. Looking at Dalio to invest inspiration , we used TipRanks’ database to find out if three stocks the billionaire recently added to the fund were making compelling results. According to the platform, the analyst community believes it is because all picks received the consensus rating “Stronger Purchase ”received Linde PLC (LIN) The first new position is in Linde, the world’s largest industrial gas production company, regardless of sales or market share. Linde produces a range of gases for industrial use and is the dominant supplier of argon, nitrogen, oxygen and hydrogen as well as niche gases such as carbon dioxide for the soft drink industry. The company produces au ch Gas storage and transfer devices, welding devices and refrigerants In short, Linde embodies Dalio’s “Diversify” dictum. Linde’s industry leadership and key products have helped the company recover from the Corona crisis. The company’s sales fell in the first half of the year 20, but rose in the second half of the year, reached pre-corona values ​​in the third quarter and exceeded these values ​​in the fourth quarter. As a sign of confidence, the company kept its dividend constant at 96 cents per common share during the “Corona year” – and in its own Linde’s most recent first-quarter statement increased the payment to $ 1,06 per share, which equates to $ 424 and yields 17% yield. The key point here is not the modest return, but the company’s confidence in the security of its positions enables him to maintain a constant profit at a time when many colleagues are cutting back on profit sharing Hold dividend So it’s no wonder that an investor like Dalio is interested in a company like Linde The billionaire’s fund closed in the fourth quarter of 20149 shares valued at USD 5.5 million at current prices. Analyst John McNulty rates Linde for BMO and expresses confidence in Linde’s current performance “LIN continues its growth strategy to deliver solid double-digit earnings growth, especially without one further macroeconomic improvement is needed In our view, management’s guide remains 11-13% conservative for 2021, thanks to the upcoming projects, continued pricing, efficiencies and solid buybacks with its strong balance sheet and cash flows that it also offers solid FCF position them plenty of dry powder for M&A, decapping etc We believe LIN is poised to continue to surprise investors and outperform the broader group in a cyclical market as the largest global industrial gas company, “said McNulty. In line with his bullish comments, McNulty rates LIN as a buy and its target price of $ 320 implies an upside of ~ 28% for the year ahead (To see McNulty’s track record, click here) Wall Street analysts largely agree on the quality of Linde stock, as evidenced by the 15 buy ratings that offset the 3 holds, which gives the stock a Strong Buy analyst’s consensus rating, the price of shares is $ 25088 and its 295 $ 73 average target price suggests ~ 18% growth is imminent (See LIN stock analysis on TipRanks) BlackRock (BLK) Next up is the world’s largest asset manager BlackRock has over $ 867 trillion in assets under management The company is one of the dominant index funds in the US financial community, posting $ 16.2 billion in revenue last year with net income of $ 4 $ 9 billion BlackRock’s latest Q4 report shows its strength, as far as the numbers can. Earnings per share were $ 1002 per share, sequential earnings of 12% and profit of 20% year-over-year with quarterly sales of $ 4.8 billion Up 17% Year-Over-Year Full Year Revenues Up 11% From 2019 BlackRock did all of this despite the corona crisis wrecking the economy in 1H20 in the first quarter of this year, BlackRock declared its regular quarterly dividend and increased its payment by 13% $ 413 per common share, assuming an annualized payment of $ 1652, that works out to yield 23% Das Un company has reliably held its dividend for the past 12 years The Dalio Fund didn’t want to miss a convincing opportunity and pulled the trigger for 19917 shares, which gave him a new position in BLK. The value of this new addition? More than $ 14 million Brian Bedell, analyst for BLK for Deutsche Bank, writes: “We view the fourth quarter results as very good, with strong long-term net inflows on his products, despite a one-time outflow from pension funds low-price equity of 55 billion USD expected to continue index assets expected in 1H21 which mgmt would have minimal impact on base fee income.In addition, the total net inflows resulted in an annualized organic base management fee growth of 13%, a quarterly record, with annualized long-term organic AuM growth from 7% We anticipate that organic base rate growth will exceed organic AuM growth by 2021 due to a flow mix targeting higher fee products for the time being. To this end, Bedell rates BLK with a buy and its price target of 837 USD suggests the stock is on an uptrend of ~ 18% (To view Bedell’s track record, click hereAnalyst Consensus Tells a Very Similar Story BLK has received 6 buy ratings against a single hold in the past three months – a clear sign that analysts are impressed with the company’s potential. Shares sell for $ 71011 and average price target of $ 83217 the stock has an upside potential of 17% (see BLK stock analysis on TipRanks) AbbVie, Inc (ABBV) AbbVie is a prominent name in the pharmaceutical industry The company is the maker of Humira, an anti-inflammatory drug used to treat a variety of chronic diseases including rheumatoid arthritis, Crohn’s disease, and psoriasis.The company’s other immunological drugs, Skyrizi and Rinvoq, were approved by the in 2019 FDA approved for the treatment of psoriasis and rheumatoid arthritis and combined sales of $ 2.3 billion last year AbbVie believes these drugs will fill the profit gap when the Humira patents expire in 2023 and sales of up to 15 by 2025 Billion US Dollars Raised Humira is currently the main driver of AbbVie’s immunology portfolio, providing $ 19 billion of the portfolio’s US $ 22 billion in annual sales, and a significant portion of the company’s total sales for all of 2020, AbbVie achieved in all Divisions 45 US dollars r8 billion in sales with adjusted diluted earnings per share of $ 1056 In addition to its high-profile anti-inflammatory line, AbbVie also has a “stall” of longstanding drugs in the market. For example, AbbVie owns Depakote, a popular anti-seizure drug, AbbVie also maintains an active one Research pipeline with numerous drug candidates completing studies in the immunology, neuroscience, oncology, and virology disciplines. For investors, AbbVie has a longstanding commitment to returning profits to shareholders and the company has an 8-year history of holding a steady and growing dividend in According to the most recent statement made this month for a May payment, AbbVie increased the dividend by 10% to $ 130 per common share. At $ 5 20 annualized, that’s a 49% return. We’re looking at stocks again, some of Dalios’ Advice embodies Dalios Company pulled the trigger for ABBV in the fourth quarter and bought 25294 shares at current valuation that’s worth $ 2.66 million Leerink analyst Geoffrey Porges reports on ABBV and is impressed with the way the company is preparing ahead of time for the loss of US exclusivity on its best-selling product, “Between Given the growth trajectory of ABBV’s ex-Humira portfolio and a broad portfolio of catalysts for early, medium and late stage assets, it is difficult to find a biopharma company that is better positioned despite the looming LOE that ABBV is on Year 2023 and has growth drivers that are better than the average sales and profit growth in the period before (2021-2022) and after (2024-2028) 2023, ”said Porges Porges gives ABBV an outperform (ie Buy) and sets a target price of $ 140, which indicates room for 33% uptrend for a year (To see Porges’ track record, click hereThere are a total of 10 ratings for ABBV stock, 9 of which are to buy – a margin that makes the analysts’ consensus rating a strong buy.The stock trades for $ 10501 and has an average price target of $ 122, which suggests a Upward movement of ~ 17% in the next 12 months (see ABBV stock analysis on TipRanks) To find great ideas for trading stocks at attractive ratings, visit TipRanks ‘Best Stocks to Buy, a newly launched tool that brings together all insights into TipRanks’ stocks Disclaimer: The opinions expressed in this article are solely those of the analysts featured The content is intended for informational purposes only. It is very important that you do your own analysis before making any investment

The Dow Jones rebounded in positive territory Apple shares and Tesla shares flashed sell signals Treasury Secretary Janet Yellen issued a Bitcoin warning

Churchill Capital Corp IV is reportedly close to finalizing the release of Lucid shares, helping to increase competition for Tesla

(Bloomberg) – Elon Musk has improved his Twitter game and owns Bitcoin and Tesla Inc Crawling during yet another bout of self-reflectionThe richest man in the world helped prices fall earlier for both on Monday after commenting over the weekend that prices for Bitcoin and smaller rival Ether “seem high, the tweet came two.” Weeks after Tesla announced it would add $ 1 billion in Bitcoin to its balance sheet, sparking a 50% jump in the price of the already-growing digital asset, both of which have risen from the lows of the day, Tesla owners have been through this before Im On May 25, 2020, Musk helped send Tesla shares down 10% after tweeted that the electric car maker’s price was “too high. At the time, Tesla shares were trading at around $ 140 on a split-adjusted basis. This downward trend didn’t last.” long on, and the stock closed at $ 81612 on Friday, while Tesla has released few details, sc Morningstar analyst David Whiston estimates the company may be over 42000 bitcoins, assuming the purchase price is at the currency’s mid-closing level in January, which was a total of about $ 2 billion on Bitcoin price on Sunday and about $ 2 billion on Monday’s low, Tesla representatives didn’t respond immediately The estimated profit on the purchase was quickly cut as Bitcoin fell as much as 17% on Monday, Tesla shares plummeted as much as 5.9%, both bouncing back from lows, with Bitcoin down 7% to 53%$ 465 and Tesla down 5% to $ 742 from 2:16 p.m. in New YorkFor more articles like this, please visit us on BloombergcomSubscribe now to stay ahead of the game with the most trusted business news source © 2021 Bloomberg LP

The global economy wants far more chips than companies can make for use in cars, data centers, and video game consoles

VITALIY KATSENELSON’S CONTRARIAN EDGE Pipelines are experiencing a renaissance, but it’s not what you think The previous renaissance in shale oil and natural gas development was far from a good result for this industry

The best dividend stocks give income and retirement portfolios a big boost These stocks offer both solid returns and strong performance

The Dow Jones Industrial Average slipped from record highs in late January as the current stock market rally continues.The best Dow Jones stocks to buy and see in February 2021 are Apple, Microsoft and Nike

(Bloomberg) – The slump in Brazilian markets on Monday is unlike any other the country has seen since the pandemic began last year, with investors dumping everything from state-owned companies to bonds to currency after President Jair Bolsonaro ousted the head of oil giant Petrobras, which mixed in government concerns and sparked a break with his government’s market-friendly pledges.The real is among the top three worst performers in the world, even after the central bank stepped in to prop up stocks are also lagging behind all major competitors, and US dollar government bonds are causing losses in emerging markets Petrobras shares fell more than 21%, their highest level in nearly a year, and leading state-controlled companies fell. Brazilian Markets Fall As Bolsonaro Advances To Interventionism “Those negative ones Signals create fear among investors and ultimately lead to a logical disinvestment of the country, “said Gregorio Velasco, head of institutional pension funds at Bci Asset Management in Santiago.” We are paying attention to this development as it can have a wider and more relevant impact on the Brazilian market The main market moves are listed: Brazilian realThe real broke the key 55 per dollar that served as support for the currency and widened losses up to 2.7% before the central bank offered dollars through foreign exchange swaps The currency fell 1% to 54424 per dollar from 2; 32 pm In New York, Bloomberg posted the second worst performance among 31 major currencies. The Ibovespa was the worst performing in the world in local currency, falling as much as 57%, the most since March. The Petrobras stock posted losses and fell more than more than due to high trading volume 20%, as analysts at Credit Suisse Group AG lowered their recommendations to JPMorgan Chase & Co The put options on the stock rose by up to 1310% Read More: Petrobras ’18 Billion Dollar Route Deepens On Series Of Downgrades Banco do Brasil SA and Eletrobras, also controlled by the Brazilian government, also fell on Monday, previously reported Lauro Jardim, columnist for O Globo that Bolsonaro was planning to replace the CEO of Banco do Brasil, who was already under political pressure Swap Rates Swap rates rose 11-22 basis points above the curve as the real fell. DI contracts now cost 436 basis points on rate hikes at the next central bank meeting in March of 38 on Friday, showing traders their Raise bets on a rate hike by half a percentage point next monthRead More: Brazil’s Central Bank Cornered as Populism Raises Rates BetsBondsBrazil’s US dollar government bonds were among the worst in emerging markets, falling around 3 cents across the curve Against the Dollar The 2050 bonds had their worst day since June, at 3 cents on the dollar to 944 cents, the lowest since July Read More: Shifts in Brazilian Yield Curve HigherPetrobras bonds were among the most actively traded high-yielding bonds, according to Trace data Emerging Market Debt The debt securities due in 2031, The most liquid of the company fell by as much as 47 cents to the dollar, the biggest slump since June The oil producer’s bonds of the century even fell by 65 cents to 107 cents to the dollar The risk premium of CDSBrazil, measured by the five-year credit default swaps, rose 22 basis points to 187, according to ICE Data Services, the biggest jump since September The move contrasts with Markit’s CDX EM index, which has barely changed Petrobras’ five-year CDS rose 35 basis points to 229, its highest level since November the dated Market implied probability of default for the next five years is now 139% (Adds charts, updates prices everywhere) For more articles like this, please visit us on bloombergcomSubscribe now to stay ahead of the game with the most trusted business news source © 2021 Bloomberg LP

HSBC is set to withdraw from US Retail Banking, a source familiar with the matter, told Reuters on Monday that Europe’s largest bank is trying to divest a business that has long underperformed the U.S. The consumer business will be part of the lender’s strategy update due Tuesday as board chairman Noel Quinn seeks to cut costs, increase fee income and continue the lender’s relocation to Asia with the sale or closure of the remaining 150 or so stores in the US, after 80 stores closed last year, would mark the end of HSBC’s struggle to restart a business that has struggled to crack down on incumbent domestic rivals

A global shortage of semiconductors has driven chip inventories to record highs, and analysts anticipate chips will continue to be in short supply at least until the end of the year as COVID-19 moves the world further into the digital realm and into the digital Area is pressing Industry is struggling to keep up with demand

Tesla’s (TSLA) investment in Bitcoin (BTC-USD) has brought the electric vehicle maker around $ 1 billion in profit – at least on paper, according to Dan Ives, CEO of Wedbush Securities

Technology Is Changing Our World, And Results Are Visible In Real Time If you grew up in the 1980s watching reruns of Star Trek, think for a moment about fantastic devices that have slipped into our lives off the screen: wearable communicators , portable computers, voice activated systems, to name a few Scotty even automated the spaceship Enterprise so that the ship could travel with only five people on board.We don’t have a Star Trek transporter, and quantum physics tells us we probably don’t will come soon, but autonomous technologies are changing the way we commute Artificial intelligence systems – thinking computers or AI – are coming into production and online and shaping the entire spectrum of the transport experience. On the roads they use, we are gradually seeing autonomous vehicles and AI-powered support services with this in mind, we have Used the TipRanks database to track two transportation-related stocks that are heavily involved in AI technology, both recently recognized by 5-star analysts who each see double-digit growth potential for Cerence, Inc (CRNC) Cerence develops AI Tech as the brain behind an autonomous vehicle system The company’s technology focuses on voice activation and enables the creation of “voice assistants” for what Cerence calls a “state-of-the-art in-car experience”, while Cerence uses voice recognition on vehicle control systems uses VR technology – and its connection to AI – for several years now.Cerence can boast of having installed its AI-powered voice systems in over 325 million vehicles that are already on the move. And the company has more than 1400 patents – so there are many more ideas pending. Cerence’s customers include names from the entire spectrum of automobiles, from famous Detroit stalwarts such as Ford and GMC to international names such as Volkswagen, Toyota and Hyundai Cerence also has the newer names in the global market Automotive scene not shunned – India’s Tata Motors is a customer, as is China’s Great Wall of China earlier this month, Cerence announced its results for the first quarter of 21, reporting results that were above expectations for both sales and earnings. The bottom line was those reported $ 95 million a year-over-year profit of 23% – and a company record EPS was a solid 59 cents per share, a 103% profit year-over-year. In addition to strong earnings, CRNC stocks have been steady over the long term Gains Made Its stock is up an impressive 362% over the past 12 months. Among the bulls is Needhams 5-Star Analyst Rajvindra Gill Who Followed Cerence and Is Impressed “With automotive manufacturing recovering from COVID-19 shutdowns and Cerence’s continued success in capturing market share, Edge sales per shipping unit are increasing Management continues to see penetration rates soar regardless of what happens to short-term auto production, “noted Gill. The analyst added,” Introducing our 10-year model [and] extending our forecast from 2025 to 2030 since we are building our confidence in the company’s ability to execute and the recurring nature of its revenue. Our model predicts revenue of $ 1B in 2030 and free cash flow of $ 367 million To this end, Gill is pricing CRNC shares as a buy, and his target price of $ 155 shows his confidence in an uptrend of ~ 26% for the year ahead. (To view Gill’s track record, click here) Among Gill’s colleagues, Apple has a consensus rating of moderate buys based on 5 buys and 3 holds with an average price target of $ 12438, analysts believe CRNC should remain range bound for now (see CRNC stock analysis on TipRanks) at Rekor Systems (REKR) Maryland-based Rekor is in an interesting niche that you probably don’t think of often – but one that brings huge benefits through the application of AI technology. Rekor focuses on security solutions for traffic control, particularly license plate recognition , but also on automated payment systems that promise to revolutionize toll roads and drive-through windows for restaurants. Rekor bases its products on AI-supported recognition technology or the ability of computer-controlled cameras and sensors to recognize and recognize individual vehicles in the flow of traffic. The volume of data is enormous; AI is required for the systems to be able to sort out the relevant vehicles. Rekor uses an open software platform in its applications and markets the know-how in a variety of niches, including the fast food and toll road industries mentioned above, but also the state-owned transportation and toll road industries public safety departments Once installed, various applications of Rekor’s AI system are helping customers improve their revenue by increasing efficiency in part, but also enabling rapid collection of tolls and fees, for the past 12 months, the REKR shares have seen tremendous growth, adding 285% Rekor’s earnings have grown with stock value. The company’s final quarter of the report, the third quarter of 20, saw gross sales increase 40% year over year to $ 2.1 million. By the end of the third quarter, the company had booked $ 6 million in total sales for 2020, 60% more than last year Northland Capital’s 5-star analyst Michael Latimore describes Rekor’s expansion potential as “performing multiple shots on goal,” “he writes,” Oklahoma has just launched its uninsured motorist program with Rekors technology in this one Year started and this model is excellently repeatable in other, larger states Texas has just passed a committee bill approving such a program, and Florida will soon follow suit. MasterCard is talking to several fast food restaurants to use Rekor technology to enhance customer experience improve (by using license plate information et to speed up customer transactions) Tollways wants to replace older RFID services with better and faster detection. In line with these bullish comments, Latimore rates the stock as an outperform (i.e. Buy) and sets a price target of $ 24, implying an uptrend of ~ 44% for a year (To see Latimore’s track record, click here) Rekor has just started to grab Wall Street’s attention and only two reviews are known so far – but both are buys.The average price target is $ 25, suggesting that of the $ 16 ~ 50% Have place67 trading price in the coming year (see REKR stock analysis on TipRanks) To find great ideas for trading AI stocks at attractive ratings, visit TipRanks ‘Best Stocks to Buy, a newly launched tool that brings together all of the insights into TipRanks’ stocks Disclaimer: The opinions expressed in this article are for exclusive use those of the featured analysts The content is intended for informational purposes only. It is very important that you conduct your own analysis before making any investment

Generic drug maker Viatris paid a dividend on Monday, but VTRS shares fell after the company released an bullish outlook for 2021. Viatris is a combination of Pfizers Upjohn and Mylan

Welcome to the Cannabis Countdown, the curated weekly roundup of the number one legal marijuana industry. In this week’s issue, we recap and count the top 10 cannabis and psychedelic stocks news for the week of Jan. until 21 February 2021 Let’s Get Started * Yahoo Finance Readers, Click Here to View Full Article 10 Red White & Blooms Platinum Vape Gets Green Light To Launch Arizona RWB Bullish Chart Setup After Arizona Launch, Become Platinum Vape -Products to be available in 5 of America’s 10 top-selling states with combined sales of over $ 7 in 20206 billion red and white & Bloom (OTCQX: RWBYF) announced this morning that Platinum Vape (PV), a wholly-owned subsidiary of RWB, is green Received light to fuel start in Arizona right now, RWB stock is consolidating beautifully into a Bull Pennant pattern and appears spring-loaded for another big uptrend, with the cannabis sector amid a very bullish uptrend, RWB’s consolidation should be short and the RWB stock will break out sooner than later READ VO PERMANENT WARC ARTICLE 9 Mushroom Brands Prepares New CSE Listing Statement As Company Works To Reinstate Trading Champignon announced that the company is on the BCSC and Canadian Securities Exchange (CSE) under the direction of world-famous depression researcher Dr Roger McIntyre as Chairman and CEO of Champignon Brands (OTCQB: SHRMF) is a research-led psychedelics company specializing in the breakthrough ketamine treatment for depression and other mental illnesses.The company works closely with subsidiaries such as AltMed Capital Corp. The Canadian Rapid Treatment Center of Excellence (CRTCE) is 100% owned by AltMed READ FULL SHRM ARTICLE 8 Jim Cramer Slams Sundial As Cannabis Company Raises M Above Warrant Exchange Sundial On Friday it was reported that it raised $ 891 million through a warrant exchange Sundial Growers (NASDAQ: SNDL) found that holders of 9,833 million warrants to buy shares in the company are exercising their warrants for cash at prices of 80 cents and $ 1 out of 10 for gross proceeds to the company in return, Sundial is set to issue 33 million new warrants that allow the holder to buy one share each at a price of $ 1 50 READ FULL SUNDIAL CRAMER ARTICLE 7 Mindset Pharma and Novamind became the North American psychedelic -Index added The index is designed to provide a measure of the performance of publicly traded North American life sciences companies focusing on psychedelics and other companies doing business in the psychedelics industry Horizons ETFs Management (Canada) announced that Mindset Pharma (OTC : MSSTF) and Novamind (CSE: NM) as quick additions in the North American Psychedelics Index, which underlies the underlying index of the Horizons Psychedelic Stock Index ETF (NEO: PSYK) READ FULL PSYCHEDELICS ETF ARTICLE 6 Creso Pharma Signs $ 25M Distribution Deal Enters New Lucrative Asian Markets Following a landmark government decision, Pakistan, of over 216 million people, has entered the billion dollar CBD market to get out of the Massive New Market Opportunity to Benefit Creso Pharma (OTC: COPHF) has signed an exclusive distribution agreement to bring the company’s innovative CBD products made from hemp to Pakistan and the Philippines. As part of the agreement, Creso will also identify additional potential target markets with an overall addressable Investigating market of approximately 750 million people including Cambodia, Afghanistan, Azerbaijan, Bangladesh, Georgia, the Maldives, Myanmar, Tajikistan, Turkmenistan, Uzbekistan and Vietnam READ FULL CPH ARTICLE 5 Revive Therapeutics Acquires Unique Psilocybin Assets Under Agreement Revive Pays a Ges official consideration of up to 10 million CAD Revive Therapeutics (OTCPK: RVVTF) announced that it has entered into a purchase agreement with Newscope Capital Corporation (OTCPK: PHRRF) to acquire full rights to PharmaTher intellectual property relating to Psilocybin PharmaTher, a wholly owned subsidiary of Newscope, is a specialist life sciences company who focuses on psychedelic pharmaceutical research and development READ FULLY REVIVE ARTICLE 4 Curaleaf: Most Expensive But Not Strongest Of The 4 Biggest MSOs The US. The MSO sector is dominated by the Big 4 players and Curaleaf is the biggest player in terms of size and market cap Curaleaf (OTCQX: CURLF) has the largest footprint among multi-state operators (MSOs) and is represented in 23 states. It also has the largest market cap among the public US. $ 11 billion cannabis company, just behind Canopy Growth (NASDAQ: CGC) However, much of that magnitude was created through acquisitions of all stocks, which resulted in massive dilution as a result, Curaleaf stocks stayed in both 2021 and 2021 behind Trulieve (OTCQX: TCNNF) and Green Thumb (OTCQX: GTBIF) last year We believe the underperformance will continue READ FULL BIG 4 MSOS ARTICLE 3 MindMed reaches agreement to acquire HealthMode, a leader in machine learning in digital medicine The acquisition will help build a comprehensive digital mental health platform for psychedelics MindMed (OTCQB: MMEDF) announced that it has acquired HealthMode, a digital medicine and therapeutics startup, uses artificial intelligence (AI) -enabled digital measurement to increase the precision and speed of clinical research and patient monitoring Ex-Pfizer (NYSE: PFE) Digital Medicine Executive Dr Daniel R. Karlin MD. M.A and former Google AI / ML industry veteran, Bradford Cross, on his executive team READ FULL ARTICLE 2 Village Farms Is A Better Choice Than Canopy Growth: Raymond James The rest of Canada’s big cannabis names may have their own strengths , but investors should put their money into Village Farms, Rahul Sarugaser, an analyst for Raymond James, says in an update to clients Sarugaser compared Village Farms (NASDAQ: VFF) stats to industry heavyweight Canopy Growth (NASDAQ: CGC), with VFF being the undoubted winner, “With VFF’s strong track record, lean cost structure (little / no depreciation) and With the largest market share relative to its size, we continue to view VFF as the best value of the Canadian Big 5, “wrote Sarugaser READ FULL VFF AGAINST WEEDS ARTICLE 1 Tilray Reports Profitable Fourth Quarter Says Aphria Merger Is On The Right Track Tilray Reported on Wednesday its first profitable quarterly period prior to its proposed merger with Aphria The Nanaimo, BC.The cannabis-based cannabis producer said a sharp increase in its adult and medicinal cannabis business resulted in $ 50 million in net sales of 7 million for the three-month period ended Dec 31, a 19% increase over last year Tilray (NASDAQ: TLRY) expects the blockbuster merger with Aphria (NYSE: APHA) to close in the second quarter of this year This makes Tilray the world’s largest cannabis company based on pro forma revenues READ FULL TLRY APHA ARTICLE Photo by Next Green Wave on Unsplash For More Information on Benzinga, click here for BenzingaCannabis Countdown Options: Top 10 News Of The Week On Marijuana And Psychedelic Industry News Of The WeekCannabis Countdown: Top 10 Stories Of Marijuana And Psychedelic Stock News Of The Week © 2021 Benzingacom Benzinga Does Not Offer Investment Advice All Rights Reserved

Goodyear Tire & Rubber Co said it would buy Cooper Tire & Rubber Co for a $ 2.8 billion deal to strengthen its portfolio in the high-margin light truck and SUV segments, as well as strengthen its presence in North America and the shares of Cooper , which historically had stronger margins than Goodyear, rose 20% in morning trading while Goodyear stock rose 3.4% The deal announced on Monday nearly doubles Goodyear’s footprint in China and expands its network of Cooper replacement tire sales from Goodyear with 2500 retail stores in the country

Dividend, New York Stock Exchange, Nasdaq

News – AU – Three days to go to Cactus, Inc To buy (NYSE: WHD) before ex-dividend day
Related Title :
Three more days to buy Cactus, Inc To buy (NYSE: WHD) Before Ex-Dividend Day
Virtu Financial, Inc (NASDAQ: VIRT) Looks like a good stock, and It& will soon be receiving an ex-dividend
It may not be a good idea to buy Fletcher Building Limited (NZSE: FBU) for the next dividend
United Bancshares, Inc (NASDAQ: UBOH) Looks like a good stock, and It& will be paying an ex-dividend soon
Four days left to buy First Financial Bancorp (NASDAQ: FFBC) Before ex-dividend day
Tennant Company (NYSE): TNC) stock will be ex-dividend in just three days
Here& # 39; s What We Like About Pact Group Holdings& # 39; (ASX: PGH) Upcoming Dividend
Voya Financial (NYSE: VOYA) could be Its a buy for the upcoming dividend
>> is China Everbright Environment Group Limited (HKG: 257) Is it a good fit for your dividend portfolio?
Nasdaq Today – Don& # 39; t Buy MidWestOne Financial Group, Inc (NASDAQ: MOFG) For the next dividend without doing

Source: https://finance.yahoo.com/news/three-days-left-buy-cactus-064704277.html